T. Rowe Price Associates’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.5M | Buy |
|
|||||
|
2025
Q1 | $76.5M | Buy |
|
|||||
|
2024
Q4 | $71.1M | Buy |
|
|||||
|
2024
Q3 | $75.3M | Sell |
|
|||||
|
2024
Q2 | $79.2M | Sell |
|
|||||
|
2024
Q1 | $82.5M | Buy |
|
|||||
|
2023
Q4 | $69.6M | Sell |
|
|||||
|
2023
Q3 | $62.1M | Buy |
|
|||||
|
2023
Q2 | $81.4M | Sell |
|
|||||
|
2023
Q1 | $83.2M | Sell |
|
|||||
|
2022
Q4 | $177M | Buy |
|
|||||
|
2022
Q3 | $165M | Sell |
|
|||||
|
2022
Q2 | $178M | Sell |
|
|||||
|
2022
Q1 | $224M | Buy |
|
|||||
|
2021
Q4 | $108M | Buy |
|
|||||
|
2021
Q3 | $96.6M | Buy |
|
|||||
|
2021
Q2 | $89.9M | Buy |
|
|||||
|
2021
Q1 | $45.4M | Sell |
|
|||||
|
2020
Q4 | $52.9M | Sell |
|
|||||
|
2020
Q3 | $44.6M | Sell |
|
|||||
|
2020
Q2 | $51.3M | Sell |
|
|||||
|
2020
Q1 | $42.5M | Buy |
|
|||||
|
2019
Q4 | $41.3M | Sell |
|
|||||
|
2019
Q3 | $36.2M | Sell |
|
|||||
|
2019
Q2 | $32.7M | Buy |
|
|||||
|
2019
Q1 | $27.7M | Buy |
|
|||||
|
2018
Q4 | $28.4M | Buy |
|
|||||
|
2018
Q3 | $28.5M | Buy |
|
|||||
|
2018
Q2 | $25.5M | Buy |
|
|||||
|
2018
Q1 | $23.8M | Sell |
|
|||||
|
2017
Q4 | $20.9M | Sell |
|
|||||
|
2017
Q3 | $36.9M | Buy |
|
|||||
|
2017
Q2 | $29.4M | Sell |
|
|||||
|
2017
Q1 | $30.8M | Buy |
|
|||||
|
2016
Q4 | $4.2M | Buy |
|
|||||
|
2016
Q3 | $3.83M | Buy |
|
|||||
|
2016
Q2 | $3.6M | Buy |
|
|||||
|
2016
Q1 | $3.06M | Buy |
|
|||||
|
2015
Q4 | $2.35M | Buy |
|
|||||
|
2015
Q3 | $1.96M | Buy |
|
|||||
|
2015
Q2 | $2.16M | Buy |
|
|||||
|
2015
Q1 | $2.74M | Sell |
|
|||||
|
2014
Q4 | $2.65M | Sell |
|
|||||
|
2014
Q3 | $2.41M | Buy |
|
|||||
|
2014
Q2 | $2.46M | Buy |
|
|||||
|
2014
Q1 | $2.03M | Sell |
|
|||||
|
2013
Q4 | $2.22M | Sell |
|
|||||
|
2013
Q3 | $2.54M | Hold |
|
|||||
|
2013
Q2 | $2.17M | Buy |
|